Raymond James Financial Services Advisors, Inc. Obs Eva Sa Transaction History

Raymond James Financial Services Advisors, Inc.

  • $73.5 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$1.1 - $2.17 $10,230 - $20,181
-9,300 Reduced 45.07%
11,334 $17,000
Q4 2021

Feb 08, 2022
SELL
$1.99 - $3.1 $37,810 - $58,900
-19,000 Reduced 47.94%
20,634 $41,000
Q3 2021

Nov 02, 2021
SELL
$2.47 - $3.34 $296 - $400
-120 Reduced 0.3%
39,634 $123,000
Q2 2021

Aug 11, 2021
BUY
$2.56 - $3.35 $204 - $268
80 Added 0.2%
39,754 $120,000
Q1 2021

May 14, 2021
BUY
$2.01 - $5.05 $79,744 - $200,353
39,674 New
39,674 $129,000

Others Institutions Holding OBSV

# of Institutions
2
Shares Held
88K
Call Options Held
0
Put Options Held
0
View Full List

About ObsEva SA

OBSV Quotes by TradingView
  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email